Nature Communications-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=842839, encodeId=3288842839c7, content=5月2日从其他子刊转投，5月4日通知送审， 不知结果如何。自我感觉我们的这个manuscript还是挺不错的，绝不是水文lol , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6525413996, createdName=ms1947553951244386, createdTime=Sat May 05 00:51:08 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555731, encodeId=120b555e3167, content=投稿后5天编辑发邮件告知已送外审.此时投稿系统不会有变化.仍然是under consideration一湖山色 2018-05-03 00:00:00 发表: 看情况, beContent=一湖山色 2018-05-03 00:00:00 发表: 看情况, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Sat May 05 00:00:00 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555642, encodeId=90f7555642a8, content=请问一般多久送审?一审又要多久额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Thu May 03 00:00:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555647, encodeId=c10055564e18, content=看情况139quZ26364(暂无昵称) 2018-05-03 00:00:00 发表: 请问一般多久送审?一审又要多久额, beContent=139quZ26364(暂无昵称) 2018-05-03 00:00:00 发表: 请问一般多久送审?一审又要多久额, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/03/1c2730f28c0fe51423d6857b150d8220.jpg, createdBy=52142074901, createdName=一湖山色, createdTime=Thu May 03 00:00:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842616, encodeId=0c44842616a4, content=4月7日投稿（从nature被拒后转投），4月25日收到送审通知，期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=887f5413968, createdName=ms4822803311816233, createdTime=Thu Apr 26 15:56:06 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555436, encodeId=19395554369e, content=投稿命中率:25.0 经验分享：我觉得NC挺难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c0a2340420, createdName=美丽的神话, createdTime=Thu Apr 26 00:00:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842411, encodeId=e6f08424111f, content=求大家公布如下的信息。以供后面的人参考。 >8月23日投稿，9月1日收到送审通知，9月30日收到审稿意见 >11月29号修回，12月1号收到送审通知，12月20日收到审稿意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Wed Apr 18 08:28:52 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842381, encodeId=2563842381d7, content=审稿速度:1.0 经验分享：还是要看运气，合不合编辑胃口。文章在chemical communication被拒，补了大半年数据投在这儿了。大修后接受，时间蛮久的。价格很贵，真心肉疼~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Mon Apr 16 16:42:26 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554873, encodeId=f1895548e347, content=我们一篇文章刚刚被接收是.相当于转化医学领域.历时10个月的评审.三轮三个评委.非常专业和严谨的要求.对于NC定位 .每人可以有不同见解.但从自己经验看应该是品味很高的.审稿速度是偏慢的.文章水平或许不及本专业的超一流杂志.但至少应该是准一流的水平.作为商业运营出色的NPG.应该是会维持这样的定位的., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Thu Apr 12 08:15:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554751, encodeId=c1d0554e5149, content=你真恶心哈哈张 2018-03-13 00:00:00 发表: 那就请你在elife 之流上发文章吧, beContent=哈哈张 2018-03-13 00:00:00 发表: 那就请你在elife 之流上发文章吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b271941298, createdName=白大褂J先生, createdTime=Tue Apr 10 00:00:00 CST 2018, time=2018-04-10, status=1, ipAttribution=)]

2018-05-05 ms1947553951244386

5月2日从其他子刊转投，5月4日通知送审，
不知结果如何。自我感觉我们的这个manuscript还是挺不错的，绝不是水文lol

25 0

[GetPortalCommentsPageByObjectIdResponse(id=842839, encodeId=3288842839c7, content=5月2日从其他子刊转投，5月4日通知送审， 不知结果如何。自我感觉我们的这个manuscript还是挺不错的，绝不是水文lol , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6525413996, createdName=ms1947553951244386, createdTime=Sat May 05 00:51:08 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555731, encodeId=120b555e3167, content=投稿后5天编辑发邮件告知已送外审.此时投稿系统不会有变化.仍然是under consideration一湖山色 2018-05-03 00:00:00 发表: 看情况, beContent=一湖山色 2018-05-03 00:00:00 发表: 看情况, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Sat May 05 00:00:00 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555642, encodeId=90f7555642a8, content=请问一般多久送审?一审又要多久额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Thu May 03 00:00:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555647, encodeId=c10055564e18, content=看情况139quZ26364(暂无昵称) 2018-05-03 00:00:00 发表: 请问一般多久送审?一审又要多久额, beContent=139quZ26364(暂无昵称) 2018-05-03 00:00:00 发表: 请问一般多久送审?一审又要多久额, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/03/1c2730f28c0fe51423d6857b150d8220.jpg, createdBy=52142074901, createdName=一湖山色, createdTime=Thu May 03 00:00:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842616, encodeId=0c44842616a4, content=4月7日投稿（从nature被拒后转投），4月25日收到送审通知，期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=887f5413968, createdName=ms4822803311816233, createdTime=Thu Apr 26 15:56:06 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555436, encodeId=19395554369e, content=投稿命中率:25.0 经验分享：我觉得NC挺难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c0a2340420, createdName=美丽的神话, createdTime=Thu Apr 26 00:00:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842411, encodeId=e6f08424111f, content=求大家公布如下的信息。以供后面的人参考。 >8月23日投稿，9月1日收到送审通知，9月30日收到审稿意见 >11月29号修回，12月1号收到送审通知，12月20日收到审稿意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Wed Apr 18 08:28:52 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842381, encodeId=2563842381d7, content=审稿速度:1.0 经验分享：还是要看运气，合不合编辑胃口。文章在chemical communication被拒，补了大半年数据投在这儿了。大修后接受，时间蛮久的。价格很贵，真心肉疼~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Mon Apr 16 16:42:26 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554873, encodeId=f1895548e347, content=我们一篇文章刚刚被接收是.相当于转化医学领域.历时10个月的评审.三轮三个评委.非常专业和严谨的要求.对于NC定位 .每人可以有不同见解.但从自己经验看应该是品味很高的.审稿速度是偏慢的.文章水平或许不及本专业的超一流杂志.但至少应该是准一流的水平.作为商业运营出色的NPG.应该是会维持这样的定位的., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Thu Apr 12 08:15:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554751, encodeId=c1d0554e5149, content=你真恶心哈哈张 2018-03-13 00:00:00 发表: 那就请你在elife 之流上发文章吧, beContent=哈哈张 2018-03-13 00:00:00 发表: 那就请你在elife 之流上发文章吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b271941298, createdName=白大褂J先生, createdTime=Tue Apr 10 00:00:00 CST 2018, time=2018-04-10, status=1, ipAttribution=)]

2018-05-05 drCHD

投稿后5天编辑发邮件告知已送外审.此时投稿系统不会有变化.仍然是under consideration一湖山色 2018-05-03 00:00:00 发表:
看情况

一湖山色 2018-05-03 00:00:00 发表: 看情况

247 0

[GetPortalCommentsPageByObjectIdResponse(id=842839, encodeId=3288842839c7, content=5月2日从其他子刊转投，5月4日通知送审， 不知结果如何。自我感觉我们的这个manuscript还是挺不错的，绝不是水文lol , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6525413996, createdName=ms1947553951244386, createdTime=Sat May 05 00:51:08 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555731, encodeId=120b555e3167, content=投稿后5天编辑发邮件告知已送外审.此时投稿系统不会有变化.仍然是under consideration一湖山色 2018-05-03 00:00:00 发表: 看情况, beContent=一湖山色 2018-05-03 00:00:00 发表: 看情况, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Sat May 05 00:00:00 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555642, encodeId=90f7555642a8, content=请问一般多久送审?一审又要多久额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Thu May 03 00:00:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555647, encodeId=c10055564e18, content=看情况139quZ26364(暂无昵称) 2018-05-03 00:00:00 发表: 请问一般多久送审?一审又要多久额, beContent=139quZ26364(暂无昵称) 2018-05-03 00:00:00 发表: 请问一般多久送审?一审又要多久额, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/03/1c2730f28c0fe51423d6857b150d8220.jpg, createdBy=52142074901, createdName=一湖山色, createdTime=Thu May 03 00:00:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842616, encodeId=0c44842616a4, content=4月7日投稿（从nature被拒后转投），4月25日收到送审通知，期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=887f5413968, createdName=ms4822803311816233, createdTime=Thu Apr 26 15:56:06 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555436, encodeId=19395554369e, content=投稿命中率:25.0 经验分享：我觉得NC挺难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c0a2340420, createdName=美丽的神话, createdTime=Thu Apr 26 00:00:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842411, encodeId=e6f08424111f, content=求大家公布如下的信息。以供后面的人参考。 >8月23日投稿，9月1日收到送审通知，9月30日收到审稿意见 >11月29号修回，12月1号收到送审通知，12月20日收到审稿意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Wed Apr 18 08:28:52 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842381, encodeId=2563842381d7, content=审稿速度:1.0 经验分享：还是要看运气，合不合编辑胃口。文章在chemical communication被拒，补了大半年数据投在这儿了。大修后接受，时间蛮久的。价格很贵，真心肉疼~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Mon Apr 16 16:42:26 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554873, encodeId=f1895548e347, content=我们一篇文章刚刚被接收是.相当于转化医学领域.历时10个月的评审.三轮三个评委.非常专业和严谨的要求.对于NC定位 .每人可以有不同见解.但从自己经验看应该是品味很高的.审稿速度是偏慢的.文章水平或许不及本专业的超一流杂志.但至少应该是准一流的水平.作为商业运营出色的NPG.应该是会维持这样的定位的., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Thu Apr 12 08:15:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554751, encodeId=c1d0554e5149, content=你真恶心哈哈张 2018-03-13 00:00:00 发表: 那就请你在elife 之流上发文章吧, beContent=哈哈张 2018-03-13 00:00:00 发表: 那就请你在elife 之流上发文章吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b271941298, createdName=白大褂J先生, createdTime=Tue Apr 10 00:00:00 CST 2018, time=2018-04-10, status=1, ipAttribution=)]

2018-05-03 Sunstar7488

请问一般多久送审?一审又要多久额

183 0

[GetPortalCommentsPageByObjectIdResponse(id=842839, encodeId=3288842839c7, content=5月2日从其他子刊转投，5月4日通知送审， 不知结果如何。自我感觉我们的这个manuscript还是挺不错的，绝不是水文lol , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6525413996, createdName=ms1947553951244386, createdTime=Sat May 05 00:51:08 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555731, encodeId=120b555e3167, content=投稿后5天编辑发邮件告知已送外审.此时投稿系统不会有变化.仍然是under consideration一湖山色 2018-05-03 00:00:00 发表: 看情况, beContent=一湖山色 2018-05-03 00:00:00 发表: 看情况, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Sat May 05 00:00:00 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555642, encodeId=90f7555642a8, content=请问一般多久送审?一审又要多久额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Thu May 03 00:00:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555647, encodeId=c10055564e18, content=看情况139quZ26364(暂无昵称) 2018-05-03 00:00:00 发表: 请问一般多久送审?一审又要多久额, beContent=139quZ26364(暂无昵称) 2018-05-03 00:00:00 发表: 请问一般多久送审?一审又要多久额, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/03/1c2730f28c0fe51423d6857b150d8220.jpg, createdBy=52142074901, createdName=一湖山色, createdTime=Thu May 03 00:00:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842616, encodeId=0c44842616a4, content=4月7日投稿（从nature被拒后转投），4月25日收到送审通知，期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=887f5413968, createdName=ms4822803311816233, createdTime=Thu Apr 26 15:56:06 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555436, encodeId=19395554369e, content=投稿命中率:25.0 经验分享：我觉得NC挺难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c0a2340420, createdName=美丽的神话, createdTime=Thu Apr 26 00:00:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842411, encodeId=e6f08424111f, content=求大家公布如下的信息。以供后面的人参考。 >8月23日投稿，9月1日收到送审通知，9月30日收到审稿意见 >11月29号修回，12月1号收到送审通知，12月20日收到审稿意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Wed Apr 18 08:28:52 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842381, encodeId=2563842381d7, content=审稿速度:1.0 经验分享：还是要看运气，合不合编辑胃口。文章在chemical communication被拒，补了大半年数据投在这儿了。大修后接受，时间蛮久的。价格很贵，真心肉疼~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Mon Apr 16 16:42:26 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554873, encodeId=f1895548e347, content=我们一篇文章刚刚被接收是.相当于转化医学领域.历时10个月的评审.三轮三个评委.非常专业和严谨的要求.对于NC定位 .每人可以有不同见解.但从自己经验看应该是品味很高的.审稿速度是偏慢的.文章水平或许不及本专业的超一流杂志.但至少应该是准一流的水平.作为商业运营出色的NPG.应该是会维持这样的定位的., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Thu Apr 12 08:15:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554751, encodeId=c1d0554e5149, content=你真恶心哈哈张 2018-03-13 00:00:00 发表: 那就请你在elife 之流上发文章吧, beContent=哈哈张 2018-03-13 00:00:00 发表: 那就请你在elife 之流上发文章吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b271941298, createdName=白大褂J先生, createdTime=Tue Apr 10 00:00:00 CST 2018, time=2018-04-10, status=1, ipAttribution=)]

2018-05-03 一湖山色

看情况139quZ26364(暂无昵称) 2018-05-03 00:00:00 发表:
请问一般多久送审?一审又要多久额

139quZ26364(暂无昵称) 2018-05-03 00:00:00 发表: 请问一般多久送审?一审又要多久额

175 0

[GetPortalCommentsPageByObjectIdResponse(id=842839, encodeId=3288842839c7, content=5月2日从其他子刊转投，5月4日通知送审， 不知结果如何。自我感觉我们的这个manuscript还是挺不错的，绝不是水文lol , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6525413996, createdName=ms1947553951244386, createdTime=Sat May 05 00:51:08 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555731, encodeId=120b555e3167, content=投稿后5天编辑发邮件告知已送外审.此时投稿系统不会有变化.仍然是under consideration一湖山色 2018-05-03 00:00:00 发表: 看情况, beContent=一湖山色 2018-05-03 00:00:00 发表: 看情况, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Sat May 05 00:00:00 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555642, encodeId=90f7555642a8, content=请问一般多久送审?一审又要多久额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Thu May 03 00:00:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555647, encodeId=c10055564e18, content=看情况139quZ26364(暂无昵称) 2018-05-03 00:00:00 发表: 请问一般多久送审?一审又要多久额, beContent=139quZ26364(暂无昵称) 2018-05-03 00:00:00 发表: 请问一般多久送审?一审又要多久额, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/03/1c2730f28c0fe51423d6857b150d8220.jpg, createdBy=52142074901, createdName=一湖山色, createdTime=Thu May 03 00:00:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842616, encodeId=0c44842616a4, content=4月7日投稿（从nature被拒后转投），4月25日收到送审通知，期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=887f5413968, createdName=ms4822803311816233, createdTime=Thu Apr 26 15:56:06 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555436, encodeId=19395554369e, content=投稿命中率:25.0 经验分享：我觉得NC挺难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c0a2340420, createdName=美丽的神话, createdTime=Thu Apr 26 00:00:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842411, encodeId=e6f08424111f, content=求大家公布如下的信息。以供后面的人参考。 >8月23日投稿，9月1日收到送审通知，9月30日收到审稿意见 >11月29号修回，12月1号收到送审通知，12月20日收到审稿意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Wed Apr 18 08:28:52 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842381, encodeId=2563842381d7, content=审稿速度:1.0 经验分享：还是要看运气，合不合编辑胃口。文章在chemical communication被拒，补了大半年数据投在这儿了。大修后接受，时间蛮久的。价格很贵，真心肉疼~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Mon Apr 16 16:42:26 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554873, encodeId=f1895548e347, content=我们一篇文章刚刚被接收是.相当于转化医学领域.历时10个月的评审.三轮三个评委.非常专业和严谨的要求.对于NC定位 .每人可以有不同见解.但从自己经验看应该是品味很高的.审稿速度是偏慢的.文章水平或许不及本专业的超一流杂志.但至少应该是准一流的水平.作为商业运营出色的NPG.应该是会维持这样的定位的., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Thu Apr 12 08:15:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554751, encodeId=c1d0554e5149, content=你真恶心哈哈张 2018-03-13 00:00:00 发表: 那就请你在elife 之流上发文章吧, beContent=哈哈张 2018-03-13 00:00:00 发表: 那就请你在elife 之流上发文章吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b271941298, createdName=白大褂J先生, createdTime=Tue Apr 10 00:00:00 CST 2018, time=2018-04-10, status=1, ipAttribution=)]

2018-04-26 ms4822803311816233

4月7日投稿（从nature被拒后转投），4月25日收到送审通知，期待ing

24 0

[GetPortalCommentsPageByObjectIdResponse(id=842839, encodeId=3288842839c7, content=5月2日从其他子刊转投，5月4日通知送审， 不知结果如何。自我感觉我们的这个manuscript还是挺不错的，绝不是水文lol , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6525413996, createdName=ms1947553951244386, createdTime=Sat May 05 00:51:08 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555731, encodeId=120b555e3167, content=投稿后5天编辑发邮件告知已送外审.此时投稿系统不会有变化.仍然是under consideration一湖山色 2018-05-03 00:00:00 发表: 看情况, beContent=一湖山色 2018-05-03 00:00:00 发表: 看情况, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Sat May 05 00:00:00 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555642, encodeId=90f7555642a8, content=请问一般多久送审?一审又要多久额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Thu May 03 00:00:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555647, encodeId=c10055564e18, content=看情况139quZ26364(暂无昵称) 2018-05-03 00:00:00 发表: 请问一般多久送审?一审又要多久额, beContent=139quZ26364(暂无昵称) 2018-05-03 00:00:00 发表: 请问一般多久送审?一审又要多久额, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/03/1c2730f28c0fe51423d6857b150d8220.jpg, createdBy=52142074901, createdName=一湖山色, createdTime=Thu May 03 00:00:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842616, encodeId=0c44842616a4, content=4月7日投稿（从nature被拒后转投），4月25日收到送审通知，期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=887f5413968, createdName=ms4822803311816233, createdTime=Thu Apr 26 15:56:06 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555436, encodeId=19395554369e, content=投稿命中率:25.0 经验分享：我觉得NC挺难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c0a2340420, createdName=美丽的神话, createdTime=Thu Apr 26 00:00:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842411, encodeId=e6f08424111f, content=求大家公布如下的信息。以供后面的人参考。 >8月23日投稿，9月1日收到送审通知，9月30日收到审稿意见 >11月29号修回，12月1号收到送审通知，12月20日收到审稿意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Wed Apr 18 08:28:52 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842381, encodeId=2563842381d7, content=审稿速度:1.0 经验分享：还是要看运气，合不合编辑胃口。文章在chemical communication被拒，补了大半年数据投在这儿了。大修后接受，时间蛮久的。价格很贵，真心肉疼~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Mon Apr 16 16:42:26 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554873, encodeId=f1895548e347, content=我们一篇文章刚刚被接收是.相当于转化医学领域.历时10个月的评审.三轮三个评委.非常专业和严谨的要求.对于NC定位 .每人可以有不同见解.但从自己经验看应该是品味很高的.审稿速度是偏慢的.文章水平或许不及本专业的超一流杂志.但至少应该是准一流的水平.作为商业运营出色的NPG.应该是会维持这样的定位的., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Thu Apr 12 08:15:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554751, encodeId=c1d0554e5149, content=你真恶心哈哈张 2018-03-13 00:00:00 发表: 那就请你在elife 之流上发文章吧, beContent=哈哈张 2018-03-13 00:00:00 发表: 那就请你在elife 之流上发文章吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b271941298, createdName=白大褂J先生, createdTime=Tue Apr 10 00:00:00 CST 2018, time=2018-04-10, status=1, ipAttribution=)]

2018-04-26 美丽的神话

投稿命中率:25.0
经验分享：我觉得NC挺难的

270 0

[GetPortalCommentsPageByObjectIdResponse(id=842839, encodeId=3288842839c7, content=5月2日从其他子刊转投，5月4日通知送审， 不知结果如何。自我感觉我们的这个manuscript还是挺不错的，绝不是水文lol , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6525413996, createdName=ms1947553951244386, createdTime=Sat May 05 00:51:08 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555731, encodeId=120b555e3167, content=投稿后5天编辑发邮件告知已送外审.此时投稿系统不会有变化.仍然是under consideration一湖山色 2018-05-03 00:00:00 发表: 看情况, beContent=一湖山色 2018-05-03 00:00:00 发表: 看情况, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Sat May 05 00:00:00 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555642, encodeId=90f7555642a8, content=请问一般多久送审?一审又要多久额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Thu May 03 00:00:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555647, encodeId=c10055564e18, content=看情况139quZ26364(暂无昵称) 2018-05-03 00:00:00 发表: 请问一般多久送审?一审又要多久额, beContent=139quZ26364(暂无昵称) 2018-05-03 00:00:00 发表: 请问一般多久送审?一审又要多久额, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/03/1c2730f28c0fe51423d6857b150d8220.jpg, createdBy=52142074901, createdName=一湖山色, createdTime=Thu May 03 00:00:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842616, encodeId=0c44842616a4, content=4月7日投稿（从nature被拒后转投），4月25日收到送审通知，期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=887f5413968, createdName=ms4822803311816233, createdTime=Thu Apr 26 15:56:06 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555436, encodeId=19395554369e, content=投稿命中率:25.0 经验分享：我觉得NC挺难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c0a2340420, createdName=美丽的神话, createdTime=Thu Apr 26 00:00:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842411, encodeId=e6f08424111f, content=求大家公布如下的信息。以供后面的人参考。 >8月23日投稿，9月1日收到送审通知，9月30日收到审稿意见 >11月29号修回，12月1号收到送审通知，12月20日收到审稿意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Wed Apr 18 08:28:52 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842381, encodeId=2563842381d7, content=审稿速度:1.0 经验分享：还是要看运气，合不合编辑胃口。文章在chemical communication被拒，补了大半年数据投在这儿了。大修后接受，时间蛮久的。价格很贵，真心肉疼~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Mon Apr 16 16:42:26 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554873, encodeId=f1895548e347, content=我们一篇文章刚刚被接收是.相当于转化医学领域.历时10个月的评审.三轮三个评委.非常专业和严谨的要求.对于NC定位 .每人可以有不同见解.但从自己经验看应该是品味很高的.审稿速度是偏慢的.文章水平或许不及本专业的超一流杂志.但至少应该是准一流的水平.作为商业运营出色的NPG.应该是会维持这样的定位的., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Thu Apr 12 08:15:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554751, encodeId=c1d0554e5149, content=你真恶心哈哈张 2018-03-13 00:00:00 发表: 那就请你在elife 之流上发文章吧, beContent=哈哈张 2018-03-13 00:00:00 发表: 那就请你在elife 之流上发文章吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b271941298, createdName=白大褂J先生, createdTime=Tue Apr 10 00:00:00 CST 2018, time=2018-04-10, status=1, ipAttribution=)]

2018-04-18 ms6267360147337765

求大家公布如下的信息。以供后面的人参考。
>8月23日投稿，9月1日收到送审通知，9月30日收到审稿意见
>11月29号修回，12月1号收到送审通知，12月20日收到审稿意见

43 0

[GetPortalCommentsPageByObjectIdResponse(id=842839, encodeId=3288842839c7, content=5月2日从其他子刊转投，5月4日通知送审， 不知结果如何。自我感觉我们的这个manuscript还是挺不错的，绝不是水文lol , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6525413996, createdName=ms1947553951244386, createdTime=Sat May 05 00:51:08 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555731, encodeId=120b555e3167, content=投稿后5天编辑发邮件告知已送外审.此时投稿系统不会有变化.仍然是under consideration一湖山色 2018-05-03 00:00:00 发表: 看情况, beContent=一湖山色 2018-05-03 00:00:00 发表: 看情况, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Sat May 05 00:00:00 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555642, encodeId=90f7555642a8, content=请问一般多久送审?一审又要多久额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Thu May 03 00:00:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555647, encodeId=c10055564e18, content=看情况139quZ26364(暂无昵称) 2018-05-03 00:00:00 发表: 请问一般多久送审?一审又要多久额, beContent=139quZ26364(暂无昵称) 2018-05-03 00:00:00 发表: 请问一般多久送审?一审又要多久额, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/03/1c2730f28c0fe51423d6857b150d8220.jpg, createdBy=52142074901, createdName=一湖山色, createdTime=Thu May 03 00:00:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842616, encodeId=0c44842616a4, content=4月7日投稿（从nature被拒后转投），4月25日收到送审通知，期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=887f5413968, createdName=ms4822803311816233, createdTime=Thu Apr 26 15:56:06 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555436, encodeId=19395554369e, content=投稿命中率:25.0 经验分享：我觉得NC挺难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c0a2340420, createdName=美丽的神话, createdTime=Thu Apr 26 00:00:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842411, encodeId=e6f08424111f, content=求大家公布如下的信息。以供后面的人参考。 >8月23日投稿，9月1日收到送审通知，9月30日收到审稿意见 >11月29号修回，12月1号收到送审通知，12月20日收到审稿意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Wed Apr 18 08:28:52 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842381, encodeId=2563842381d7, content=审稿速度:1.0 经验分享：还是要看运气，合不合编辑胃口。文章在chemical communication被拒，补了大半年数据投在这儿了。大修后接受，时间蛮久的。价格很贵，真心肉疼~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Mon Apr 16 16:42:26 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554873, encodeId=f1895548e347, content=我们一篇文章刚刚被接收是.相当于转化医学领域.历时10个月的评审.三轮三个评委.非常专业和严谨的要求.对于NC定位 .每人可以有不同见解.但从自己经验看应该是品味很高的.审稿速度是偏慢的.文章水平或许不及本专业的超一流杂志.但至少应该是准一流的水平.作为商业运营出色的NPG.应该是会维持这样的定位的., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Thu Apr 12 08:15:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554751, encodeId=c1d0554e5149, content=你真恶心哈哈张 2018-03-13 00:00:00 发表: 那就请你在elife 之流上发文章吧, beContent=哈哈张 2018-03-13 00:00:00 发表: 那就请你在elife 之流上发文章吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b271941298, createdName=白大褂J先生, createdTime=Tue Apr 10 00:00:00 CST 2018, time=2018-04-10, status=1, ipAttribution=)]

2018-04-16 ms7253200455804543

审稿速度:1.0
经验分享：还是要看运气，合不合编辑胃口。文章在chemical communication被拒，补了大半年数据投在这儿了。大修后接受，时间蛮久的。价格很贵，真心肉疼~

51 0

[GetPortalCommentsPageByObjectIdResponse(id=842839, encodeId=3288842839c7, content=5月2日从其他子刊转投，5月4日通知送审， 不知结果如何。自我感觉我们的这个manuscript还是挺不错的，绝不是水文lol , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6525413996, createdName=ms1947553951244386, createdTime=Sat May 05 00:51:08 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555731, encodeId=120b555e3167, content=投稿后5天编辑发邮件告知已送外审.此时投稿系统不会有变化.仍然是under consideration一湖山色 2018-05-03 00:00:00 发表: 看情况, beContent=一湖山色 2018-05-03 00:00:00 发表: 看情况, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Sat May 05 00:00:00 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555642, encodeId=90f7555642a8, content=请问一般多久送审?一审又要多久额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Thu May 03 00:00:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555647, encodeId=c10055564e18, content=看情况139quZ26364(暂无昵称) 2018-05-03 00:00:00 发表: 请问一般多久送审?一审又要多久额, beContent=139quZ26364(暂无昵称) 2018-05-03 00:00:00 发表: 请问一般多久送审?一审又要多久额, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/03/1c2730f28c0fe51423d6857b150d8220.jpg, createdBy=52142074901, createdName=一湖山色, createdTime=Thu May 03 00:00:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842616, encodeId=0c44842616a4, content=4月7日投稿（从nature被拒后转投），4月25日收到送审通知，期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=887f5413968, createdName=ms4822803311816233, createdTime=Thu Apr 26 15:56:06 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555436, encodeId=19395554369e, content=投稿命中率:25.0 经验分享：我觉得NC挺难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c0a2340420, createdName=美丽的神话, createdTime=Thu Apr 26 00:00:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842411, encodeId=e6f08424111f, content=求大家公布如下的信息。以供后面的人参考。 >8月23日投稿，9月1日收到送审通知，9月30日收到审稿意见 >11月29号修回，12月1号收到送审通知，12月20日收到审稿意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Wed Apr 18 08:28:52 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842381, encodeId=2563842381d7, content=审稿速度:1.0 经验分享：还是要看运气，合不合编辑胃口。文章在chemical communication被拒，补了大半年数据投在这儿了。大修后接受，时间蛮久的。价格很贵，真心肉疼~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Mon Apr 16 16:42:26 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554873, encodeId=f1895548e347, content=我们一篇文章刚刚被接收是.相当于转化医学领域.历时10个月的评审.三轮三个评委.非常专业和严谨的要求.对于NC定位 .每人可以有不同见解.但从自己经验看应该是品味很高的.审稿速度是偏慢的.文章水平或许不及本专业的超一流杂志.但至少应该是准一流的水平.作为商业运营出色的NPG.应该是会维持这样的定位的., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Thu Apr 12 08:15:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554751, encodeId=c1d0554e5149, content=你真恶心哈哈张 2018-03-13 00:00:00 发表: 那就请你在elife 之流上发文章吧, beContent=哈哈张 2018-03-13 00:00:00 发表: 那就请你在elife 之流上发文章吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b271941298, createdName=白大褂J先生, createdTime=Tue Apr 10 00:00:00 CST 2018, time=2018-04-10, status=1, ipAttribution=)]

2018-04-12 drCHD

我们一篇文章刚刚被接收是.相当于转化医学领域.历时10个月的评审.三轮三个评委.非常专业和严谨的要求.对于NC定位 .每人可以有不同见解.但从自己经验看应该是品味很高的.审稿速度是偏慢的.文章水平或许不及本专业的超一流杂志.但至少应该是准一流的水平.作为商业运营出色的NPG.应该是会维持这样的定位的.

218 0

[GetPortalCommentsPageByObjectIdResponse(id=842839, encodeId=3288842839c7, content=5月2日从其他子刊转投，5月4日通知送审， 不知结果如何。自我感觉我们的这个manuscript还是挺不错的，绝不是水文lol , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6525413996, createdName=ms1947553951244386, createdTime=Sat May 05 00:51:08 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555731, encodeId=120b555e3167, content=投稿后5天编辑发邮件告知已送外审.此时投稿系统不会有变化.仍然是under consideration一湖山色 2018-05-03 00:00:00 发表: 看情况, beContent=一湖山色 2018-05-03 00:00:00 发表: 看情况, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Sat May 05 00:00:00 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555642, encodeId=90f7555642a8, content=请问一般多久送审?一审又要多久额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/24/37a4feeb3c1e411ba42c689b6a9b8211.jpg, createdBy=949a2213185, createdName=Sunstar7488, createdTime=Thu May 03 00:00:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555647, encodeId=c10055564e18, content=看情况139quZ26364(暂无昵称) 2018-05-03 00:00:00 发表: 请问一般多久送审?一审又要多久额, beContent=139quZ26364(暂无昵称) 2018-05-03 00:00:00 发表: 请问一般多久送审?一审又要多久额, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/03/1c2730f28c0fe51423d6857b150d8220.jpg, createdBy=52142074901, createdName=一湖山色, createdTime=Thu May 03 00:00:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842616, encodeId=0c44842616a4, content=4月7日投稿（从nature被拒后转投），4月25日收到送审通知，期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=887f5413968, createdName=ms4822803311816233, createdTime=Thu Apr 26 15:56:06 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555436, encodeId=19395554369e, content=投稿命中率:25.0 经验分享：我觉得NC挺难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c0a2340420, createdName=美丽的神话, createdTime=Thu Apr 26 00:00:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842411, encodeId=e6f08424111f, content=求大家公布如下的信息。以供后面的人参考。 >8月23日投稿，9月1日收到送审通知，9月30日收到审稿意见 >11月29号修回，12月1号收到送审通知，12月20日收到审稿意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Wed Apr 18 08:28:52 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842381, encodeId=2563842381d7, content=审稿速度:1.0 经验分享：还是要看运气，合不合编辑胃口。文章在chemical communication被拒，补了大半年数据投在这儿了。大修后接受，时间蛮久的。价格很贵，真心肉疼~ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30f15414081, createdName=ms7253200455804543, createdTime=Mon Apr 16 16:42:26 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554873, encodeId=f1895548e347, content=我们一篇文章刚刚被接收是.相当于转化医学领域.历时10个月的评审.三轮三个评委.非常专业和严谨的要求.对于NC定位 .每人可以有不同见解.但从自己经验看应该是品味很高的.审稿速度是偏慢的.文章水平或许不及本专业的超一流杂志.但至少应该是准一流的水平.作为商业运营出色的NPG.应该是会维持这样的定位的., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/05/99da7e395c3265e1e941df7f6db671c6.jpg, createdBy=63721421663, createdName=drCHD, createdTime=Thu Apr 12 08:15:00 CST 2018, time=2018-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554751, encodeId=c1d0554e5149, content=你真恶心哈哈张 2018-03-13 00:00:00 发表: 那就请你在elife 之流上发文章吧, beContent=哈哈张 2018-03-13 00:00:00 发表: 那就请你在elife 之流上发文章吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b271941298, createdName=白大褂J先生, createdTime=Tue Apr 10 00:00:00 CST 2018, time=2018-04-10, status=1, ipAttribution=)]

2018-04-10 白大褂J先生

你真恶心哈哈张 2018-03-13 00:00:00 发表:
那就请你在elife 之流上发文章吧

哈哈张 2018-03-13 00:00:00 发表: 那就请你在elife 之流上发文章吧

224 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务